Physician profile
Anna Catherine Yates
NPI 1457977696
$5,405.89
in general payments reported to CMS, 2019-2025
13 companies · $5,232 in 2025
The $5,232 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $66.30 · 2024: $108 · 2025: $5,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,379 · Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,379.34 |
| Food and Beverage | $526.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,045.38 | 2025 | |
| Myriad Women'S Health, INC. | $66.30 | 2023 | Myrisk |
| Exeltis, USA INC. | $35.14 | 2025 | Slynd |
| Coopersurgical, INC. | $31.92 | 2025 | Sos, Ally II Ups |
| Merck Sharp & Dohme LLC | $30.62 | 2024 | Keytruda |
| Organon LLC | $28.85 | 2024 | |
| Biogen, INC. | $25.04 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $24.78 | 2025 | |
| Astellas Pharma US INC | $24.46 | 2025 | Veozah |
| Abbvie INC. | $24.46 | 2024 | |
| Myriad Genetic Laboratories, INC. | $23.99 | 2024 | Myrisk |
| Pacira Pharmaceuticals Incorporated | $23.72 | 2025 | Exparel |
| Solventum Corporation | $21.23 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Yates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.